PLx Pharma, Inc. (PLXP) Social Stream



PLx Pharma, Inc. (PLXP): $0.02

0.00 (0.00%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

F

Add PLXP to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#279 of 380

in industry

PLX PHARMA INC (PLXP) Price Targets From Analysts

Use the tables below to see what analysts covering PLX PHARMA INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-15 3 $29 $22 $25.5 $0.087 29210.34%
2021-12-07 3 $29 $14 $21.666 $0.087 24803.45%
2022-03-14 2 $16 $12 $14 $0.087 15991.95%
2022-05-13 2 $10 $10 $10 $0.087 11394.25%
2022-05-17 2 $11 $10 $10.5 $0.087 11968.97%
NA 1 $NA $NA $NA $0.087 NA%

Price Target Last Issued NA NA, NA

The Trend in the Analyst Price Target


PLXP's average price target has moved down $1.5 over the prior 14 months.

PLXP reports an average of 324.75% for its upside potential over the past 4 days.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-05-13 3 16 10 13.0 2.59 401.93%
2022-05-13 2 10 10 10.0 2.59 286.1%
2022-05-13 2 16 10 13.0 2.59 401.93%
2022-05-13 3 10 10 10.0 2.59 286.1%
2022-05-17 2 11 10 10.5 3.02 247.68%

PLXP Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 1 1 0 0 0 2

The Trend in the Broker Recommendations


PLXP's average broker recommendation rating worsened by 0.83 over the prior 151 days.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for PLXP as an investment opportunity.

  • In terms of how PLX PHARMA INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 42.51% of that group.
  • PLXP has a higher upside potential (average analyst target price relative to current price) than 699.53% of all US stocks.
  • PLXP has a lower variance in analysts' estimates than -16.92% of Pharmaceutical Products stocks.
  • PLXP has a higher average analyst price target than 189.79% of Healthcare stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to PLX PHARMA INC are ELDN, BLCM, and ARDX.

Make investment decisions regarding PLXP using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!